According to a recent study, individuals with chronic renal failure who are receiving hemodialysis may benefit clinically from omega 3 by having higher levels of the protective vascular calcification inhibitors: fetuin-A and osteoprotegerin [36]. Here, AHSG is linked to chronic kidney disease.